A phase I/II study of THR-149 for the treatment of edema associated with diabetic retinopathy

Trial Profile

A phase I/II study of THR-149 for the treatment of edema associated with diabetic retinopathy

Planning
Phase of Trial: Phase I/II

Latest Information Update: 11 May 2017

At a glance

  • Drugs THR 149 (Primary)
  • Indications Diabetic macular oedema
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 11 May 2017 According to a ThromboGenics media release, the company is planning to initiate this trial in H1 2018.
    • 21 Mar 2017 New trial record
    • 16 Mar 2017 According to a ThromboGenics media release, the company is planning to initiate this trial in 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top